Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
26 /100
MEDIUM RISK
Score updated Aug 28, 2026

OLMA — Olema Pharmaceuticals, Inc. Dilution Risk Tracker

Track OLMA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OLMA — Get alerts when the score changes →

As of August 28, 2026, Olema Pharmaceuticals, Inc. (OLMA) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Olema Pharmaceuticals, Inc. has a market capitalization of $1.15B, 87.50M shares outstanding, 202 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for OLMA.
🔔 Track OLMA — Get forecast alerts →

Market Data

Market Cap$1.15B
Shares Outstanding87.50M
Float59.72M
Cash$461.07M
Debt$3.96M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 30.1% shares (2026Q1 vs prior)
202 institutional holders · 121.67M shares
#1 JANUS HENDERSON GROUP PLC 14.22M shares
#2 FMR LLC 10.39M shares
#3 Paradigm Biocapital Advisors LP 8.02M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest15.96M
Days to Cover18.2
% of Float26.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-12-31
3 FORM3 2026-04-29
4 INSIDER TRANSACTION 2026-04-29
4 INSIDER TRANSACTION 2026-03-05
4 INSIDER TRANSACTION 2026-02-17
Full SEC filing analysis available with free account

Recent News

No recent news

Factual OLMA Dilution Snapshot

Olema Pharmaceuticals, Inc. (OLMA) has a DilutionScore of 26/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track OLMA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OLMA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for OLMA
OLMA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.